Arch Therapeutics (ARTH)
(Delayed Data from OTC)
$1.09 USD
-0.01 (-0.46%)
Updated Jun 18, 2024 01:19 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Arch Therapeutics, Inc. [ARTH]
Reports for Purchase
Showing records 21 - 40 ( 115 total )
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Arch Files SEC Form 10-Q Reporting Results of Quarter Ending June 30
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
We?re All Still Waiting for Big News From Arch Therapeutics
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Arch Therapeutics Reports March Quarter In-Line One Day After Raising Cash
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Arch Therapeutics Announces Attendance at Major Wound Healing Conference
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Potentially Transformative Period Ahead; Strategic Decisions Near-Term; Lowering Target to $2.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
We are transferring lead coverage to Scotty Henry due to the departure of the previous lead-covering analyst
Provider: Roth Capital Partners, Inc.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
We are transferring coverage, placing Under Review, and removing PT''s and estimates
Provider: Roth Capital Partners, Inc.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Raising Our Rating and Target Price for Arch Therapeutics - Updating Model After 10-Q
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Reports Financial Results of FY2018 ending Sept. 30.
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Arch Therapeutics Gets Much Anticipated FDA Approval for AC5 Topical Gel.
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.